Monday, December 11, 2006 - 3:00 PM
0549

Beyond spinosad: Biological efficacy and attributes of XDE-175, a novel semi-synthetic spinosyn

James E. Dripps, jedripps@dow.com, Harvey A. Yoshida, hyoshida@dow.com, Anthony W. Weiss, awweiss@dow.com, Jesse M. Richardson, jmrichardson@dow.com, Brian D. Olson, bdolson@dow.com, B. Basabri, bbisabri@dow.com, Fikru Haile, fhaile@dow.com, Melissa Willrich Siebert, mwillrichsiebert@dow.com, Alan G. McFadden, aggmcfadden@dow.com, James P. Mueller, jpmueller@dow.com, and Mark B. Hertlein, mbhertlein@dow.com. Dow AgroSciences, 9330 Zionsville Road, Indianapolis, IN

Text Not Available.